BioImagene has said that its iScan slide scanners address the challenges posed by traditional microscopy by providing a powerful, highly automated and collaborative platform that supports the entire
Azzalure has received the UK approval for the temporary improvement in the appearance of moderate to severe glabellar lines seen at the frown, in adult men and women
The proceeds will be used for the ongoing clinical development of KBPA 101 in nosocomial pneumonia and to advance KBSA 201, a fully human IgG monoclonal antibody against
The agreement permits Barr and Teva to launch generic versions of these Xopenex inhalation solution dosages under terms of a non-exclusive license commencing on February 17, 2013. The
IDM Pharma, a biopharmaceutical company, has announced that the European Commission has formally granted a centralized marketing authorization for Mepact for the treatment of patients with non-metastatic, resectable
Endologix, a developer of minimally invasive therapies for the treatment of vascular disease, has received the FDA approval of the IntuiTrak express delivery system for the Powerlink XL
Switzerland-based pharmaceutical company Synosia Therapeutics has entered into a second agreement with Roche, pursuant to which, Synosia gains access to a new-generation 5-HT6 antagonist in Phase I to
This contract allows any branch of the Department of Defense, Veterans Administration Medical Centers or government agencies to purchase directly from Swissray. With exercisable option years the contract
Mr Rosen will continue in his position with Fresenius Medical Care for the time necessary to ensure a smooth transition of the CFO responsibilities. Mr Rosen has been
Human Genome Sciences, a biopharmaceutical company, has announced that Albuferon met its primary endpoint of non-inferiority to peginterferon alfa-2a in Achieve 1, a Phase III clinical trial of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.